which antiretroviral therapy is most likely to induce dyslipidemia in a patient who has acquired immune deficiency syndrome (aids)?
<answer> Highly active antiretroviral therapy is most likely to induce dyslipidemia in a patient who has acquired immune deficiency syndrome. <context> Acquired immune deficiency syndrome, acquired immunodeficiency syndrome, AIDS, CAD, coronary arteries, coronary artery disease, CD4 cells, endocarditis, HAART, heart attack, high blood pressure, highly active antiretroviral therapy, HIV, human immunodeficiency virus, hypertension, immune, immune defense system, immune system, immunocompromised, ...